Aksys raises $15 million to develop PHD system:
This article was originally published in Clinica
Executive Summary
US haemodialysis company Aksys (Lincolnshire, Illinois) has increased its available cash to $31m following a $15m share placing with a single institutional investor on June 30. The offering was made at an 8% discount, but will help fund the company's commercial operations into 2004, said senior VP and CFO Larry Damron. The new financing will be used to fund the launch plans for Aksys' PHD system.